From Wikipedia, the free encyclopedia
COVID-19 vaccination in Mainland China is an ongoing immunisation campaign against
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the
ongoing pandemic in the country .
As of May 2021, six vaccines in
Mainland China have been approved for conditional marketing or emergency use, and can be used for vaccination by vaccination units
[1] .
Vaccines on order
As of June 10, 2021, a total of 7 vaccines in Mainland China have been approved for conditional marketing or emergency use.
Early EUA Approved Vaccines
Vaccine
Vaccine Type
Manufacturer
Doses Required for Vaccination
Phase III clinical trial effective rate
Emergency Use Authorization
Deployment
Date of Listing in EUL by
COVAX
Sinopharm (BBIBP-CorV)
Inactivated
Sinopharm (Beijing)
2
[2]
86%
[3]
December 31, 2020
December 31, 2020
May 7, 2021
Sinovac (CoronaVac)
Inactivated
Sinovac
2
[2]
50.4% - 83.5%
[4]
[5]
[6]
February 5, 2021
February 5, 2021
June 1, 2021
Sinopharm (WIBP-CorV)
Inactivated
Sinopharm (Wuhan)
2
[2]
72.8%
[7]
February 25, 2021
February 25, 2021
No
CanSino (Convidecia)
Adenoviridae
CanSino
1
[2]
65.7%
[8]
February 25, 2021
February 25, 2021
No
Anhui Zhifei (ZF2001)
[9]
Protein subunit
Anhui Zhifei
3
[2]
[10]
March 10, 2021
March 10, 2021
No
Others Vaccines Authorised after May 2021
See also
Reference
China
vaccination
^
"新冠病毒疫苗接种问答来了!涉及34个关键问题" . 中国新闻网 . 2021-04-01. Retrieved 2021-04-02 .
^
a
b
c
d
e
"新冠病毒疫苗接种问答来了!涉及34个关键问题" . 中国新闻网 . 2021-04-01. Retrieved 2021-04-02 .
^
"National Health Regulatory Authority approves Sinopharm COVID-19 vaccine" . BNA. 2020-12-13. Archived from
the original on 2021-02-14. Retrieved 2021-02-14 .
^
"Sinovac: Brazil results show Chinese vaccine 50.4% effective" . BBC News . 2021-01-13. Archived from
the original on 2021-03-10. Retrieved 2021-03-13 .
^
"Turkey set to receive 'effective' COVID-19 vaccine amid calls for inoculation" . Daily Sabah . 2020-12-25. Archived from
the original on 2021-01-08. Retrieved 2021-03-13 .
^
"Indonesia grants emergency use approval to Sinovac's vaccine, local trials show 65% efficacy" . The Straits Times . 2021-01-11. Archived from
the original on 2021-01-30. Retrieved 2021-03-13 .
^ Al Kaabi, Nawal; Zhang, Yuntao; Xia, Shengli; Yang, Yunkai; Al Qahtani, Manaf M.; Abdulrazzaq, Najiba; Al Nusair, Majed; Hassany, Mohamed; Jawad, Jaleela S. (2021-05-26).
"Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults: A Randomized Clinical Trial" . JAMA .
doi :
10.1001/jama.2021.8565 .
ISSN
0098-7484 .
^
"CanSinoBIO's COVID-19 vaccine 65.7% effective in global trials, Pakistan official says" . Reuters. 2021-02-08. Retrieved 2021-02-08 .
^
"智飞生物业绩看上去很美,但撑得起3000亿市值吗?" . 界面新闻 . 2021-04-20. Retrieved 2021-04-20 .
^
"智飞生物冠病疫苗临床结果显示有效率达97%" . 联合早报 (in Simplified Chinese). 2021-03-26. Retrieved 2021-04-03 .